ANNOVIS BIO
1055 Westlakes Drive
Suite 300

Berwyn, PA 19312

Website Design by 

Lamnia-Logo-White-PNG.png

(c) 2019 Annovis Bio, All Rights Reserved 

 

The idea that sticky brain plaques cause Alzheimer’s disease began as an interesting hypothesis and eventually became drug industry dogma. Now, after a string of clinical trial failures, that hypothesis looks less credible than ever. 

Raymond J. Tesi STAT News April 30, 2019

Aducanumab's failure puts pressure on field to look beyond amyloid

Ned Pagliarulo March 22, 2019

After amyloid failures, it’s time to take a new tack for treating Alzheimer’s

WE ARE DEVELOPING DRUGS FOR ALZHEIMER’S AND PARKINSON’S DISEASE, INCLUDING THE ORPHAN INDICATION DEMENTIA AND ALZHEIMER’S IN DOWN SYNDROME

Our novel approach to addressing chronic and acute neurodegeneration offers new hope in the fight against the largest unmet need of an aging population

The idea that sticky brain plaques cause Alzheimer’s disease began as an interesting hypothesis and eventually became drug industry dogma. Now, after a string of clinical trial failures, that hypothesis looks less credible than ever. 

ALZHEIMER'S DISEASE DRUG FAILURE

Amyloid Plaque and Aβ is NOT The Only Answer

After amyloid failures, it’s time to take a new tack for treating Alzheimer’s

Raymond J. Tesi STAT News April 30, 2019

Aducanumab's failure puts pressure on field to look beyond amyloid

Ned Pagliarulo March 22, 2019